Drug Search Results
More Filters [+]

Coleneuramide

Alternative Names: coleneuramide, mcc-257, mcc257, mcc 257
Latest Update: 2007-12-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Coleneuramide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Polyneuropathies

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MCC-257-A03

P2

Completed

Polyneuropathies

None

Recent News Events

Date

Type

Title